Market News Archives

Fiber, Funding, and GPUs: Why This Nokia–Nvidia–KGPCo Triangle Should Be on Investors’ Screens -( $NOK $NVDA )

by John F. Heerdink, Jr. March 18, 2026 412Views 0Likes

Nvidia’s (NVDA) billion-dollar bet on Nokia (NOK) adds an AI-powered tailwind to what was already a quietly strategic broadband story for KGPCo and BEAD-focused operators. With GPUs now effectively hitching a ride on fiber builds, the network economy just picked up a…

March 18, 2026 – Oil, Inflation and a Grumpy Fed: Why Wall Street Just Marked Down Its Soft-Landing Fantasy -( $HTFL $LULU $VIX Rise!)

by John F. Heerdink, Jr. March 18, 2026 2991Views 0Likes

Stocks staged a Fed-day post St. Patty's Day hungover tantrum Wednesday, as investors discovered that “higher for longer” still means exactly what it sounds like. Indexes and Rates The Dow industrials fell sharply, at one point flirting with a 700‑plus point slide,…

Interest Rates on Hold, Nerves Not So Much: How the Fed Is Playing Economic Jenga -( $SPY $VIX $NVDA $SWMR )

by John F. Heerdink, Jr. March 18, 2026 491Views 0Likes

The Federal Reserve’s latest rate decision landed not with a bang, but with the kind of carefully measured thud Wall Street has come to admire: steady, data-dependent, and just hawkish enough to keep the bond vigilantes awake. Fed Holds the Line as…

Amazon’s $600 Billion Cloud Dream: Can Wall Street Handle This Much AI Optimism? -( $AMZN $SPY )

by John F. Heerdink, Jr. March 18, 2026 327Views 0Likes

Amazon is effectively telling Wall Street that its cloud is no longer just a utility—it is the monetization engine of the AI era, with Andy Jassy sketching a path to an eye‑popping (600) billion dollars in annual AWS revenue by 2036. The…

March 17, 2026 – Gold Glitters, Yields Flinch: A St. Paddy’s Market Recap With a Wink -( $EPRX $GLD $INTG $LMND $OPEN $SOAR Rise!)

by John F. Heerdink, Jr. March 17, 2026 2842Views 0Likes

Wall Street spent St. Patrick’s Day edging back into the green, as investors raised a cautious toast to the Federal Reserve and NVIDIA’s AI ambitions rather than to rapid-fire rate cuts. Indices and macro mood US stocks advanced for a second straight…

Eupraxia’s Six-Month Data Put EP-104GI On The Map – And EPRX On More Screens -( $EPRX $IBB $SNY $XBI )

by John F. Heerdink, Jr. March 17, 2026 575Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX) is behaving less like a sleepy small-cap from Victoria and more like a company auditioning for prime time in the EoE treatment lineup. With six‑month symptom data from its RESOLVE trial now in hand and a fortified balance…

War, Oil and Interest Rates: Central Banking’s Least Favorite Love Triangle -( $DIA $QQQ $SPY $VIX )

by John F. Heerdink, Jr. March 17, 2026 397Views 0Likes

Central banks just stumbled into a new plot twist: an oil‑driven inflation shock from the Iran war just as the global economy was finally catching its breath, but the story is more policy tightrope than doom spiral. The good news—for now—is that…

Diabetes Devices Go Prime Time: How MMED, MODD, and PODD Are Turning Pumps Into a Portfolio Theme -( $MDT $MMED $MODD $PODD )

by John F. Heerdink, Jr. March 17, 2026 435Views 0Likes

MiniMed’s (MMED) IPO, Modular Medical’s (MODD) financing sprint, and Insulet’s (PODD) new data readout together sketch a surprisingly upbeat picture for diabetes tech investors watching the next leg of insulin-delivery innovation. Diabetes Tech Steps Into the Spotlight In early March, MiniMed Group,…

Nvidia’s GTC 2026: When AI’s Arms Dealer Bets on the Network Itself -( $META $NBIS $NOK $NVDA )

by John F. Heerdink, Jr. March 16, 2026 489Views 0Likes

Nvidia’s GTC 2026 is less a tech conference and more a macroeconomic indicator with catering at this point, and CEO Jensen Huang’s keynote in San Jose is the closest thing Wall Street has to appointment television. Expectations are tuned, once again, to…

New York’s First Severe Mpox Case Arrives – And So Does a New Chapter for Preparedness -( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. March 16, 2026 329Views 0Likes

New York City woke up this week to a headline it doesn’t particularly enjoy: its first documented case of severe mpox, specifically the clade I strain associated with more serious disease and higher mortality. Health officials confirmed that the patient had recently…

Market News

Your Guide To Staying Informed In The Markets